AbCellera: Dart-Board Approach Reflects Trading Premium (Upgrade)
Corroborated by 1 source from 1 publisher
globaltech4h ago
TL;DR
According to seekingalpha.com, follow-Up on Original Sell Article I have written two sell articles on AbCellera (ABCL) on Seeking Alpha that have highlighted the company's talented and technologically savvy, yet expensive, approach to drug discovery.